David Brooks was recognized with Hodgkin’s lymphoma

8

Bournemouth midfielder David Brooks has been recognized with Stage II Hodgkin’s lymphoma, a type of most cancers, and can start therapy subsequent week. His prognosis has been described as “positive”.

Brooks, who joined Cherries from Sheffield United 2018 in 2018, left worldwide service with Wales final week after a medical examination and the analysis has since been confirmed.

“This is a very difficult message for me to write. I have been diagnosed with stage II Hodgkin’s lymphoma and will start a treatment course next week “, it was said in a press release from the participant.

“Even though this has come as a shock to myself and my family, the prognosis is positive and I am convinced that I will fully recover and start playing as soon as possible.

“I would like to show my appreciation to doctors, nurses, consultants and staff who have treated me for their professionalism, warmth and understanding during this period.

“I want to thank everyone at the Football Association of Wales, because without the prompt attention of their medical teams, we might not have discovered the disease. I would also like to thank AFC Bournemouth for all the support and help over the past week.

“Although I appreciate that there will be media attention and interest, I would like to ask that my privacy be respected in the coming months and I will share updates on my progress when I can.

pic.twitter.com/G7U9FyvIdD

– David Brooks (@ DRBrooks15) October 13, 2021

“In the meantime, thank you to everyone for their support messages – it means so much and will continue to do so in the coming months. I look forward to meeting you all again and playing the sport I love soon. ”

Bournemouth CEO Neil Blake has promised that the membership will do “every thing doable” to help Brooks and his household throughout his therapy and restoration.

For extra from Jamie Spencer, comply with him on Twitter and Facebook!

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More